Boehringer Ingelheim International GmbH - Strategic SWOT Analysis Review
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Boehringer Ingelheim International GmbH - Key Facts
Boehringer Ingelheim International GmbH - Key Employees
Boehringer Ingelheim International GmbH - Key Employee Biographies
Boehringer Ingelheim International GmbH - Major Products and Services
Boehringer Ingelheim International GmbH - History
Boehringer Ingelheim International GmbH - Company Statement
Boehringer Ingelheim International GmbH - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Boehringer Ingelheim International GmbH - Business Description
Business Segment: Animal Health
Overview
Performance
Business Segment: Biopharmaceuticals
Overview
Performance
Key Stats
Business Segment: Human Pharmaceuticals
Overview
Performance
Business Segment: Other Sales
Overview
Performance
Geographical Segment: Asia/Australia/Africa
Performance
Geographical Segment: Europe
Performance
Geographical Segment: The Americas
Performance
R&D Overview
Boehringer Ingelheim International GmbH - Corporate Strategy
Boehringer Ingelheim International GmbH - SWOT Analysis
SWOT Analysis - Overview
Boehringer Ingelheim International GmbH - Strengths
Boehringer Ingelheim International GmbH - Weaknesses
Boehringer Ingelheim International GmbH - Opportunities
Boehringer Ingelheim International GmbH - Threats
Boehringer Ingelheim International GmbH - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Boehringer Ingelheim International GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Boehringer Ingelheim International GmbH, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jun 03, 2019: Boehringer Ingelheim and PharmAccess launch digital healthcare program in Kenya
May 31, 2019: Boehringer collaborates with Gubra for obesity treatments
May 23, 2019: Network of 1,500 stroke-ready clinics across Europe
May 14, 2019: Digital transformation: Boehringer Ingelheim fosters cooperation with innovative partners
Apr 18, 2019: Boehringer partners PureTech to develop immuno-oncology candidates
Apr 17, 2019: Financial year 2018: Boehringer Ingelheim grows and invests
Feb 25, 2019: Boehringer Ingelheim: New chief medical officer appointed
Feb 12, 2019: Boehringer Ingelheim (Canada) and IBM Canada announce first of its kind collaboration to integrate blockchain technology into clinical trials
Jan 17, 2019: Boehringer Ingelheim Biopharmaceuticals China expands commercial manufacturing capacities
Jan 08, 2019: Adimab provides year-end update on 2018 partnership activities
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
Boehringer Ingelheim International GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights
Boehringer Ingelheim International GmbH (Boehringer), a subsidiary of CH Boehringer Sohn AG & Co KG, is a pharmaceutical company that conducts research, development, manufacture and sale of pharmaceuticals. It offers a wide range of products including human diseases, animal health care products and biopharmaceuticals. The company’s products are used in the treatment of central nervous system disorders, respiratory diseases, cardiovascular diseases, metabolic disorders, cancer, urological and viral conditions, among others. It operates facilities for manufacture pharmaceuticals, chemical active substances, and medical products. Boehringer operates globally through affiliates and is headquartered in Ingelheim am Rhein, Rheinland-Pfalz, Germany.
Boehringer Ingelheim International GmbH Key Recent Developments
Jun 03,2019: Boehringer Ingelheim and PharmAccess launch digital healthcare program in Kenya
May 31,2019: Boehringer collaborates with Gubra for obesity treatments
May 23,2019: Network of 1,500 stroke-ready clinics across Europe
May 14,2019: Digital transformation: Boehringer Ingelheim fosters cooperation with innovative partners
Apr 18,2019: Boehringer partners PureTech to develop immuno-oncology candidates
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.